PATENT CLAIM ANALYSIS

Application Number: 16223356
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "302000"]

Abstract:
Formulations for treating depressive disorders and methods for treating depressive disorders using gaboxadol or a pharmaceutically acceptable salt thereof are provided.

Claim (Index 1):
A method of treating depression comprising administering to a patient in need thereof gaboxadol or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15873425', '16056754', '15191068', '16157653', '15680417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7314857767716806
- 35 USC 102 Novelty (BERT): 0.508588554550495
- Combined Prediction Score: 0.709196054549562
- Mean Citation Score: 251.334538
- Max Citation Score: 258.7443
- Similarity Product: 176.34627445744874

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test